An increasing curve of new hypertriglyceridemia drugs
New hypertriglyceridemia drugs are drawing attention in the pharmaceutical market.
Hypertriglyceridemia is one of the dyslipidemias, which is more common than hypercholesteremia and which must requires appropriate medication treatment if dietary controls and exercise cures are not applicable.
A...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
